Pre-market hot trades in US stocks: Core Scientific, Inc. pre-market down 10.50%; Coreweave pre-market down 3.24%
I'm LongbridgeAI, I can summarize articles.Core Scientific, Inc. pre-market down 10.50%; Coreweave pre-market down 3.24%; LogProstyle pre-market up 191.30%; Artelo Biosciences pre-market up 120.96%; Sonnet BioTherapeutics pre-market up 43.40%
Popular Pre-Market Trades in U.S. Stocks
Core Scientific is down 10.50% in pre-market trading. Based on recent important news:
-
On July 7, CoreWeave announced it would acquire Core Scientific in an all-stock transaction valued at $20.40 per share, leading to a drop in stock price.
-
On July 7, the market reacted negatively to the acquisition news of Core Scientific, with pre-market stock price falling by 7.9%.
-
On July 4, analysts stated that Core Scientific is not the best investment choice, rating it as a buy.
Coreweave is down 3.24% in pre-market trading. Based on recent important news:
-
On January 20, the company’s stock price fell 57% last year, the CEO suddenly resigned, and ratings were downgraded multiple times, as it is undergoing a significant business transformation to become a leading chip design and manufacturing company, causing stock price volatility.
-
On January 19, after the implementation of new policies, if the company's performance declines, the number of shares employees receive will decrease, and the value of the shares will also shrink as the stock price falls.
-
On January 19, news that Anhui will lead the national biopharmaceutical alliance procurement in 2025 triggered a decline in the stock prices of several innovative drug companies, with Innovent Biologics experiencing the largest drop, over 10%.
Top Gainers in Pre-Market Trading in U.S. Stocks
LogProstyle is up 191.30% in pre-market trading. Based on recent important news:
-
On July 7, LogProstyle became the first Japanese company to directly list on a major U.S. stock exchange, driving a significant increase in stock price.
-
On July 7, the company's board approved a stock repurchase plan, boosting market confidence and further increasing stock price.
-
On July 7, the market reacted positively to the company's repurchase plan, with stock prices continuing to rise.
Artelo Biosciences is up 120.96% in pre-market trading. Based on recent important news:
-
On July 7, the company issued a statement regarding future events and financial performance, reminding investors to be cautious with forward-looking statements that may affect stock price volatility.
-
On July 5, Huazheng Index announced ESG rating results, impacting market confidence in related companies.
-
On July 4, insiders from DL Holdings Group purchased shares, enhancing market confidence.
Sonnet BioTherapeutics is up 43.40% in pre-market trading. Based on recent important news:
-
On May 15, analysts rated Sonnet Biotherapeutics Holdings Inc as "buy," with a target price of $20, far above the current stock price of $1.29, leading to optimistic market expectations and driving stock price up
-
On May 17th, the average consensus recommendation from the biotechnology and medical research peer group was "Buy," further boosting investor confidence.
-
On June 9th, the active market in the innovative drug sector drove the sentiment of pharmaceutical stocks, with Sonnet BioTherapeutics benefiting from market sentiment, leading to a rise in its stock price